EpiPen Maker Must Pay $465 Million to Settle Lawsuit
Summary: Mylan has agreed to pay $465 million after misclassifying the Epipen as generic and therefore avoiding Medicaid payments. Last…
Summary: Mylan has agreed to pay $465 million after misclassifying the Epipen as generic and therefore avoiding Medicaid payments. Last…